Imparting Temperature Sensitivity and Attenuation in Ferrets to A/Puerto Rico/8/34 Influenza Virus by Transferring the Genetic Signature for Temperature Sensitivity from Cold-Adapted A/Ann Arbor/6/60

Journal of Virology

Volumn 78, Issue 2, 2004, Pages 995-998

  Jin, Hong ^a   Zhou, Helen ^a   Lu, Bin ^a   Kemble, George ^a  

^a MEDIMMUNE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INACTIVATED VACCINE; INFLUENZA VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EMBRYO; FERRET; GENE LOCUS; GENE TRANSFER; INFLUENZA VIRUS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PUERTO RICO; TEMPERATURE SENSITIVE MUTANT; VACCINE PRODUCTION; VIRUS ATTENUATION; VIRUS RECOMBINANT; VIRUS STRAIN;

ANIMALS; CELL LINE; COLD; DISEASE MODELS, ANIMAL; FERRETS; HUMANS; INFLUENZA A VIRUS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MUTATION; RECOMBINATION, GENETIC; RESPIRATORY SYSTEM; TEMPERATURE; VACCINES, ATTENUATED; VIRAL PROTEINS;

EID: 0346057858     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.78.2.995-998.2004     Document Type: Article

References (19)

1. Anchlan, D., S. Ludwig, P. Nymadawa, J. Mendsaikhan, and C. Scholtissek. 1996. Previous H1N1 influenza A viruses circulating in the Mongolian population. Arch. Virol. 141:1553-1569.
2. Beare, A. S., G. C. Schild, and J. W. Craig. 1975. Trials in man with live recombinants made from A/PR/8/34 (H0 N1) and wild H3 N2 influenza viruses. Lancet ii:729-732.
3. Ennis, F. A., M. Verbonitz, P. Reichelderfer, and S. Daniel. 1976. Recombination of influenza A virus strains: effect on pathogenicity. Dev. Biol. Stand. 33:220-225.
4. Fodor, E., M. Crow, L. J. Mingay, T. Deng, J. Sharps, P. Fechter, and G. G. Brownlee. 2002. A single amino acid mutation in the PA subunit of the influenza virus RNA polymerase inhibits endonucleolytic cleavage of capped RNAs. J. Virol. 76:8989-9001.
5. Fodor, E., L Devenish, O. G. Engelhardt, P. Palese, G. G. Brownlee, and A. García-Sastre. 1999. Rescue of influenza A virus from recombinant DNA. J. Virol. 73:9679-9682.
6. Hoffmann, E., S. Krauss, D. Perez, R. Webby, and R. G. Webster. 2002. Eight-plasmid system for rapid generation of influenza virus vaccines. Vaccine 20:3165-3170.
7. Hoffmann, E., G. Neumann, Y. Kawaoka, G. Hobom, and R. G. Webster. 2000. A DNA transfection system for generation of influenza A virus from eight plasmids. Proc. Natl. Acad. Sci. USA 97:6108-6113.
8. Huygelen, C. 1977. Laboratory and clinical evaluation of new live influenza virus vaccines. Need for minimum requirements. Dev. Biol. Stand. 39:155-160.
9. Jin, H., B. Lu, H. Zhou, C. Ma, J. Zhao, C. F. Yang, G. Kemble, and H. Greenberg. 2003. Multiple amino acid residues confer temperature sensitivity to human influenza virus vaccine strains (FluMist) derived from cold-adapted A/Ann Arbor/6/60. Virology 306:18-24.
10. Kilbourne, E. D. 1969. Future influenza vaccines and the use of genetic recombinants. Bull. W. H. O. 41:643-645.
11. Li, S., C. Liu, A. Klimov, K. Subbarao, M. L. Perdue, D. Mo, Y. Ji, L. Woods, S. Hietala, and M. Bryant. 1999. Recombinant influenza A virus vaccines for the pathogenic human A/Hong Kong/97 (H5N1) viruses. J. Infect. Dis. 179: 1132-1138.
12. Luytjes, W., M. Krystal, M. Enami, J. D. Pavin, and P. Palese. 1989. Amplification, expression, and packaging of foreign gene by influenza virus. Cell 59:1107-1113.
13. Murphy, B. R., and K. Coelingh. 2002. Principles underlying the development and use of live attenuated cold-adapted influenza A and B virus vaccines. Viral Immunol. 15:295-323.
14. Neumann, G., T. Watanabe, H. Ito, S. Watanabe, H. Goto, P. Gao, M. Hughes, D. R. Perez, R. Donis, E. Hoffmann, G. Hobom, and Y. Kawaoka. 1999. Generation of influenza A viruses entirely from cloned cDNAs. Proc. Natl. Acad. Sci. USA 96:9345-9350.
15. Perez, D. R., and R. O. Donis. 2001. Functional analysis of PA binding by influenza A virus PB1: effects on polymerase activity and viral infectivity. J. Virol. 75:8127-8136.
16. Simonsen, L., M. J. Clarke, G. D. Williamson, D. F. Stroup, N. H. Arden, and L. B. Schonberger. 1997. The impact of influenza epidemics on mortality: introducing a severity index. Am. J. Public Health 87:1944-1950.
17. Subbarao, E. K., E. J. Park, C. M. Lawson, A. Y. Chen, and B. R. Murphy. 1995. Sequential addition of temperature-sensitive missense mutations into the PB2 gene of influenza A transfectant viruses can effect an increase in temperature sensitivity and attenuation and permits the rational design of a genetically engineered live influenza A virus vaccine. J. Virol. 69:5969-5977.
18. Thompson, W. W., D. K. Shay, E. Weintraub, L. Brammer, N. Cox, L. J. Anderson, and K. Fukuda. 2003. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 289:179-186.
19. Voeten, J. T., R. Brands, A. M. Palache, G. J. van Scharrenburg, G. F. Rimmelzwaan, A. D. Osterhaus, and E. C. Claas. 1999. Characterization of high-growth reassortant influenza A viruses generated in MDCK cells cultured in serum-free medium. Vaccine 17:1942-1950.